Navigation Links
Europe Unlikely to Meet Measles Goals: Report
Date:1/7/2009

Suboptimum vaccination rates cast doubt on ability to eliminate disease by 2010

WEDNESDAY, Jan. 7 (HealthDay News) -- Hope is fading for the elimination of measles in Europe by 2010, as a new report reveals lower-than-optimal vaccination rates in five countries where outbreaks have occurred in recent years.

Eighty-five percent of the more than 12,000 measles cases reported on the continent during the years 2006 and 2007 occurred in Germany, Italy, Romania, Switzerland and the United Kingdom. The cases mostly involved children who were never or incompletely vaccinated, according to a report published online in The Lancet.

Researchers at State Serum Institute in Copenhagen, Denmark, found that vaccination rates for the two-dose preventative in these countries were below the 95 percent minimum recommended by the World Health Organization. Reaching and maintaining that level over the long-term is considered vital for measles elimination.

"The suboptimum vaccination coverage raises serious doubts that the goal of elimination by 2010 can be attained," the report's authors concluded. "Achievement and maintenance of optimum vaccination coverage, and improved surveillance, are the cornerstones of the measles elimination plan for the Europe."

While most of the 12,132 European cases occurred in children, almost a fifth were incurred by people age 20 or older during the two years studied. Only 7 measles-related deaths were noted. Most of the cases originated in the country they were reported in, although 210 cases were "imported" from either Asia or another European country.

"The more pressing question is how much measles does Europe export to countries with poor health systems and high fatality rates," wrote Jacques R. Kremer and Claude P. Muller of the WHO Regional Reference Laboratory for Measles and Rubella in Sante, Luxembourg, in an accompanying comment in the journal. "Importations o
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Surveyed Neurologists in Both the U.S. and Europe Would Welcome an Antiepileptic Drug That is Administered Once-Daily
2. S*BIO Announces Collaboration with Onyx for JAK2 Inhibitors in the North American and European Markets
3. Hard To Treat Diseases (HTDS) Completes E Europe Merger
4. Schering-Plough Announces European Submission of Fertility Medicine Corifollitropin Alfa
5. Annual Congress European Association of Urology: highlights in Stockholm
6. Development of Novel Assays Vital for the European Immunoassay Diagnostics Market
7. New Roche Dual Target HIV-1 Test Approved for Use in European Union
8. Comparable data on maternal and infant in Europe available for the first time
9. Seven life scientists get research boost to set up in Europe
10. DNA2.0 Expands European Presence By Opening UK Office: Experienced Life Sciences Executive, Dr. Michael Dyson, to Lead European Operations
11. Pharmaceutical Water Markets, the Economic Crunch Creates New Opportunities in Southern and Eastern Europe

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Europe Unlikely to Meet Measles Goals: Report
Europe Unlikely to Meet Measles Goals: Report
(Date:11/20/2009)... , PRINCETON, NJ, Nov. 20 /PRNewswire-FirstC...ay that a Special Meeting of Shareholders will be ...the Meeting is to consider approval of two special...pprove and authorize the sale of all or substantia... the terms provided for in the asset purchase agre...
(Date:11/20/2009)... Senators and Congressmen in...le Over their Health Care Vote , ...- Senators and congressmen running for re-election...litical guru Charlie Cook, may come to regret voti...are bill, according to a breaking Zogby Internatio...
(Date:11/20/2009)... , HAIFA, Israel, November 20 /PRNewsw...orp. (CVSL.OB), http://www.CVSLMEDICAL.COM , a le... technology, today announced that,the company,s Bo...plications,in Europe, Canada and the Far East for ...re" applicable for all angioplasty (PCTA) procedur...
(Date:11/20/2009)...n editorial published online November 20 in the J... the exaggerated fears and hopes that often appear...l provides guidance for both the media and journal...rtz, M.D., M.S., and Steven Woloshin, M.D., M.S., ...uth Institute for Health Policy and Clinical Pract...
(Date:11/20/2009)... Based out of Dallas, TX, th...same quality products that are made in the USA. ,...er 20, 2009 -- blue sky scrubs is an independent m... quality, design, production and distribution of h...ly only selling their products via their online bo...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:Blue Sky Scrubs Secures a Second Texas Manufacturer 2
...April 21 MedCath Corporation,(Nasdaq: MDTH ) ann...econd,quarter of fiscal 2008, which ended March 31...iscal 2008 outlook. MedCath,s preliminary earnings...nounced on March 24, 2008 that it had entered into...
...ess to feature U.S. Health and Human Services Secr... for value-based health system;, Event to convene...s the health care industr...r U.S. Presidential candidates Sen. Barack Obama, ...
..., April 21 As the pace of global,competition hast...earch,groups to keep up. Effective market research...tion by using customers, markets and competitors a... research groups are able to deliver,forward-looki...
... may exist in observational studies that compare o...results questionable. That is the conclusion of a...CANCER, a peer-reviewed journal of the American Ca...curacies. , Clinical trials are considered the go...
...search supported by the Canadian Cancer Society sh...eight and inactive, which could put them at risk f...ng. , These findings tell us that we need to loo...a Research Chair at the University of Alberta in E...
...allergen species, avoiding high pollen hours can h...-- For gardeners with allergies, it can be difficu...e to cope with the misery of sneezing, itchy eyes,...mptoms," Dr. Warren Filley, an allergist/immunolog...
Other Medicine News:Health News:MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook 2Health News:MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook 3Health News:MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook 4Health News:MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook 5Health News:MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook 6Health News:MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook 7Health News:5th Annual World Health Care Congress Kicks off April 21 With Obama, Clinton, McCain Health Care Policy Advisor Presidential Health Care Agenda Forum 2Health News:Creating an Effective Market Research Group to Generate High-Impact Business Results 2Health News:Study reveals inaccuracies in studies of cancer treatment 2Health News:Obesity, inactivity as common among cancer survivors as rest of Canadians, study shows 2Health News:Obesity, inactivity as common among cancer survivors as rest of Canadians, study shows 3Health News:Allergies Can Dig Into Gardening's Fun 2
(Date:11/20/2009)..., , GLENWOOD, Ill., Nov. 20 /PRNewswire-Fir...se financial results for the fiscal fourth quarter...mber 1, 2009. ,, The company will host a confer...09, at 2:00 p.m. Eastern Time. Investors may acces...e United States and Canada), or 480-629-9835 (inte...
(Date:11/20/2009)..., , HARRISBURG, Pa., Nov. 20 /PRNewswire-...n providing free H1N1 flu shots to members of prio...he vaccine. ,, A total of 18 clinics are being ...s are from 2 p.m. to 8 p.m. Hours on Saturday, Nov... the clinics will operate from 2 p.m. to 8 p.m. ,...
(Date:11/20/2009)..., , NEW YORK, Nov. 20 ...rch report is available in its catalogue. ,, G... Increasing Adoption to Drive Growth ,, http...oring-Blood-Glucose-Market-(SMBG )-Increasing-Adop...p;utm_medium=pr&utm_campaign=prnewswire ,,...
Breaking Medicine Technology:Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 3Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 4Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 5Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 6Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 7Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 8Dialysis Patient Citizens Endorses Kidney Community Campaign to Improve Survival Rates of First Year Dialysis Patients 48206 1Dialysis Patient Citizens Endorses Kidney Community Campaign to Improve Survival Rates of First Year Dialysis Patients 48206 2New essays examine the use of fMRI to recognize deceit 48204 1New essays examine the use of fMRI to recognize deceit 48204 2HUYA Bioscience Announces Strategic Collaboration With the Shenyang Pharmaceutical University 12526 1HUYA Bioscience Announces Strategic Collaboration With the Shenyang Pharmaceutical University 12526 2HUYA Bioscience Announces Strategic Collaboration With the Shenyang Pharmaceutical University 12526 3
...High Concentrations Reached in Key Lung Compartmen...,/PRNewswire-FirstCall/ -- Arpida Ltd. today annou...ith AR-709. These radiolabelled,Human Microdose st...rs. , This groundbreaking study is the first ever ...ncentrations in lung compartments.,The results sho...
... DEERFIELD, Ill., March 29, 2007 /PRNewswire-First... final Phase I/II data for its,adjuvant-free inves...ns to initiate a Phase III clinical trial of the c...sults. , The Phase I/II study indicated that Baxte...t low doses, and induces substantial,levels of cro...
Other Medicine Technology:Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 2Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 3Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 4Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 5Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 2Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 3Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 4Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 5
Cushing Periosteal Elevator
Adson Periosteal Elevators
Ohl Periosteal Elevators
Seldin Periosteal Elevators
Medicine Products: